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Abstract
Antimicrobial resistance in the food chain is currently a subject of a major interest. The 
excessive use or rather misuse of antimicrobials coupled with a poor hygiene in the food 
production chain has led to a rise of resistant zoonotic bacteria, commonly transmitted 
by food. They pose a serious threat to human health. Campylobacteriosis is the lead-
ing bacterial food-borne illness and most commonly reported zoonosis in humans in the 
European Union for more than a decade. Salmonellosis is most frequently diagnosed in 
food-borne outbreaks. Fluoroquinolones are considered as critically important for treat-
ment of severe cases of both zoonoses in humans. Due to an extremely prevalent resistant 
isolates, especially from broilers and meat, also the treatment of human Campylobacter 
infections with fluoroquinolones has become compromised. Salmonella isolates from 
poultry and poultry meat tend to be highly resistant to fluoroquinolones as well. Beside 
the resistance to this group of antibiotics, the threat of multiple drug resistant (MDR) 
Campylobacter and Salmonella strains is discussed in the light of most recent reports of 
animal, food and human clinical surveillance systems.
Keywords: Campylobacter, Salmonella, antimicrobial resistance, food safety, food 
production chain, multiple drug resistance
1. Introduction
Antimicrobials are indispensable in human medicine for treating and preventing infectious 
diseases. In addition, the same classes of antimicrobials are extensively used in livestock not 
only for the treatment and prevention of infections but also for the growth promotion [1]. The 
latter has, however, been banned in the European Union (EU) since 2006 [2].
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
The amounts of antimicrobials utilised in livestock are vast and often exceed those in humans. 
Data suggest that in the EU approximately 70% of antimicrobials were sold for use in live-
stock in 2014 [3]. The consumption of antimicrobials in humans and animals has indeed been 
associated with the occurrence of antimicrobial resistance (AMR) in zoonotic bacteria [3], 
which are the causative agents of zoonoses and can be transmitted directly between animals 
and humans or via the food chain. AMR in zoonotic bacteria is a subject of major concern.
Even though AMR is an ancient and naturally occurring phenomenon in some bacteria [4], the 
excessive use of antimicrobials in humans and livestock, as well as poor hygiene conditions 
and practices in the food production chain, accelerates the emergence of resistance in zoonotic 
bacteria [5]. The alarming consequence of AMR coupled with the paucity of novel antimicro-
bials is the rise in the frequency of multidrug resistant (MDR) zoonotic bacteria that may lead 
to an impaired response to antimicrobial therapy or ultimately even treatment failure [6].
The most current data regarding AMR in zoonotic bacteria are published annually by 
European Food Safety Authority (EFSA) and European Centre for Disease Control and 
Prevention (ECDC), but usually with a two-year delay in publishing. According to the recent 
report on AMR in zoonotic bacteria in 2016 [5], resistance in Salmonella and Campylobacter 
is considered of the highest concern. The scope of this review is, therefore, to discuss and 
emphasise the current trends of AMR in Salmonella and Campylobacter in the light of the recent 
EFSA/ECDC report, and the role of whole genome sequencing (WGS) in the surveillance of 
AMR in Salmonella and Campylobacter along the food production chain.
2. Common zoonoses in Europe
For more than a decade, campylobacteriosis has been the most common zoonosis in Europe. 
Salmonellosis is the second most commonly reported enteric infection, and the leading cause 
of food-borne outbreaks. Campylobacter and Salmonella combined accounted for almost 95% of 
the reported and confirmed zoonoses cases in 2016 (Figure 1).
Salmonellosis is a food-borne gastrointestinal infection caused by zoonotic bacteria Salmonella 
spp. Several thousand serovars of Salmonella spp. enterica exist, yet only some are causing dis-
ease symptoms. Nontyphoidal serovars are transmitted via the food chain, whereas typhoi-
dal serovars, the causative agents of typhoid fever, are restricted to humans [8]. Whilst the 
majority of nontyphoidal Salmonella infections are self-limiting and do not require any anti-
biotic treatment, some cases result in life-threatening systemic infections that must be treated 
with antimicrobials, primarily fluoroquinolones (FQ) or third-generation cephalosporins [5]. 
Resistance to these drugs may jeopardise the efficiency of the antimicrobial therapy.
Campylobacter spp. are common gut commensals of several animal species, especially birds [9], 
and the leading cause of gastroenteritis in humans, yet the infections often go unreported. The 
majority of campylobacterioses are caused by two species, namely Campylobacter jejuni and 
Campylobacter coli. Symptoms of campylobacteriosis are also usually mild and self-limiting, 
although some patients with acute infections that can trigger autoimmune inflammatory con-
ditions need to be treated with antimicrobials, primarily macrolides and FQ [5]. Emergence of 
resistance in Campylobacter is common and thus of concern.
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In the Member States (MS) of the EU monitoring and reporting data on zoonoses and AMR 
for Salmonella and Campylobacter from animals, food, feed and humans are mandatory [10]. 
Comparing AMR data from different countries and assessing trends has long been challeng-
ing due to inadequate harmonisation of the methodology and reporting among the MS [11]. 
Recently, great progress has been made in terms of harmonisation of AMR surveillance pro-
grams, especially for food animals and foods with the new legislation [12]. In addition, a 
protocol for harmonised monitoring of AMR in humans has been developed [13], but it is not 
a legal document that would obligate the MS to its implementation.
3. Salmonella
3.1. Prevalence of nontyphoidal Salmonella in the food chain
According to the recent report on trends and sources of zoonoses, zoonotic agents and food-
borne outbreaks in 2016 published by EFSA/ECDC [7], the declining trend of salmonellosis in 
Europe has ended. In 2016, there were 94,530 confirmed cases of salmonellosis with the high-
est notification rate per 100,000 population in Eastern Europe (in average 46.9 per 100,000), 
mostly on the account of Czech Republic (110) and Slovakia (97.7), followed by Northern 
(20.6), Western (18.8) and Southern Europe (13.0). Additionally, Salmonella was most regu-
larly detected in food-borne outbreaks (22.3%), which have resulted in the highest burden of 
hospitalisations (45.6% of the total number of hospitalised cases) and deaths (50% of the total 
number of deaths among outbreak cases) [7]. Outbreaks were linked to several sources, e.g., 
Polish eggs [14], infant formula [15] and sesame seeds [16].
Salmonella was the most prevalent in meat from turkeys (7.74% of the samples tested positive) 
and from broilers (6.39%), as well as dried seeds (8.0%) [7], which are an important source 
of infections, especially due to a long shelf life and low moisture [17]. Chicken, turkey and 
other avian species are commonly inhabited with Salmonella without noticeable symptoms 
[18], which is in addition to the practices in the food production chain [19], considered the 
highest risk for contamination of meat products. Even though Salmonella was significantly 
less frequently detected in eggs and their products, they remain the most important source 
Figure 1. Common zoonoses in Europe in 2016. STEC: Shiga toxin-producing Escherichia coli [7].
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of outbreaks [14, 20], most probably due to a large worldwide consumption coupled with 
low concentrations of Salmonella that cannot be detected [7]. Rapid methods with improved 
sensitivity are thus needed to address this shortfall, e.g., real-time recombinase polymerase 
amplification [21] or sequence-based methods.
3.2. Antimicrobial resistance in nontyphoidal Salmonella spp.
The most recent data (from 2016) on AMR in Salmonella from poultry, meat thereof, and 
humans are provided by EFSA/ECDC [5], whereas data on other livestock are presented in 
the last-year report [22]. Generally, as shown in Figure 2, the isolates of Salmonella spp. along 
the food production chain tend to be highly resistant to tetracyclines and ciprofloxacin (in 
average in the EU up to 65%), sulfonamides (56%) and ampicillin (45%) with the highest 
observed frequency in poultry, meat thereof and pigs, respectively (Figure 2). Resistance 
rates seemed to be higher in Southern or Eastern Europe than in Northern or Western Europe 
[5, 22]. Such extreme rates of resistance that could indeed reflect an extensive use of these 
three antimicrobials in livestock [23] are of concern and could be facilitating further dissemi-
nation of AMR.
Sulfonamides and ampicillin were the former first-line drugs against salmonellosis [24]. 
Nevertheless, ampicillin, a critically important antimicrobial [25], is used for treating commu-
nity acquired pneumonia, complicated severe acute malnutrition and sepsis in neonates and 
children [26]. In contrast, sulfonamides and tetracyclines are classified as highly important 
antimicrobials [25]. Sulfonamides are the first-line drugs against urinary tract infections and 
tetracyclines against Chlamydia trachomatis and cholera [26].
Figure 2. Prevalence of resistance in Salmonella spp. AMP: ampicillin, SUL: sulfonamides, CIP: ciprofloxacin, TET: 
tetracyclines [5, 22].
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FQ resistance to ciprofloxacin or nalidixic acid that is reflecting similar genetic mechanisms 
[11] was remarkably high in isolates from poultry meat (Figure 2), followed by poultry [5] and 
has steeply increased since 2004 [27]. That is of concern, because FQ are in addition to third-
generation cephalosporins clinically important for the treatment of salmonellosis and several 
other infections, yet both may be used in livestock.
3.3. FQ resistance and third-generation cephalosporins resistance in Salmonella
Broiler meat (64.7%), broilers (53.8%), turkey (50.5%) and turkey meat (43.7%) were the main 
sources of FQ resistance. In contrast, isolates from pigs, humans and laying hens had bet-
ter susceptibility (Figure 3) [5, 22]. The ranges of FQ resistance, however, varied extremely 
among the countries and even regions. In Spain, for example, isolates from pigs in Catalonia 
(50%) [28] and humans in Extremadura (35%) [29] exhibited much higher levels of FQ resis-
tance than reported by EFSA/ECDC for Spain (7 and 14.8%, respectively).
FQ resistance in isolates from broilers and meat thereof was in average most prevalent in 
Southern (62.2, 70.1%, respectively) and Eastern Europe (65.5, 71.5%, respectively) and 
exceeded 90% in Cyprus, Slovenia and Croatia (Figure 4). Of note, only a minority of the MS 
from Northern Europe reported these data [5]. A rapid increase in FQ resistance is evident 
in Europe, for instance, in isolates from broilers in Spain resistance increased from 0 [30] to 
55.6% in just a few years.
Figure 3. Rates of FQ resistance in isolates of Salmonella spp. from various sources: broiler meat, broilers, turkeys, turkey 
meat, laying hens, humans and pigs, respectively [5, 22].
Figure 4. Prevalence of FQ-resistant isolates of Salmonella spp. from broilers, meat thereof and humans in Europe. UK: 
United Kingdom [5].
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In contrast, the proportions of FQ resistance in humans were significantly lower (11%) [5] and 
has remained at a relatively stable level since 2009 [31]. The biggest share of FQ resistance 
was detected in Northern Europe, mostly on the account of Estonia (36.0%), Finland (26.3%), 
Norway (24.7%) and Ireland (22.9%) (Figure 4). Human-associated serovars commonly 
detected in Europe [32–35] that frequently exhibited FQ resistance were S. Infantis (23.4%) 
and S. Kentucky (85.8%) [5].
FQ resistance is a result of a complex mechanism, but it is still not fully understood [36]. Many 
point mutations in the genes encoding for gyrase and topoisomerase, the two enzymes that 
are inhibited by FQ, were identified as the causative agents [37]. In addition, plasmids may 
harbour genes for efflux pumps, target protection proteins or drug-modifying enzymes [38].
Resistance to third-generation cephalosporins was rare in humans as well as in livestock [5], 
yet when combined with FQ resistance, it poses a serious risk to human health, in terms of 
reducing the efficiency of these drugs against salmonellosis and thus leaving only the reserve 
antimicrobials as a feasible therapy option [24]. Resistance to cephalosporins is conferred by 
genes encoding for AmpC β-lactamase as well as for various extended spectrum β-lactamase 
(ESBL) that can be located on plasmids. Such isolates were observed in Germany [39] and are 
assumed to have clonally spread from livestock to humans. Worryingly, in Portugal, more 
than a third of the isolates from broiler meat (39.4%) exhibited resistance to cefotaxime and 
ceftazidime and in Italy 12% from broilers [5]. In addition, combined resistance to FQ and 
cephalosporins was detected in poultry and humans in Spain, Belgium and France [40, 41].
Salmonella in the food production chain presents an important reservoir of genetic resistance 
determinants, which could be mobilised and transferred via the food chain to either other 
human pathogens or commensal bacteria [42]. Notably, importation of meat products [43] 
and travelling in endemic areas [44], where the rates of resistance to critically important anti-
microbials are alarmingly high [45], were linked to the global spread of MDR strains.
3.4. MDR and combined resistance to fluoroquinolones and third-generation 
cephalosporins
In general, 26.5% of the human isolates of Salmonella and 50.3% of broiler meat displayed 
MDR phenotype (defined as resistant to at least three antimicrobials of the nine antimicro-
bial classes tested). The highest prevalence of MDR isolates from humans was observed in 
Portugal (51%) and from broiler meat in Slovenia (100%) [5]. MDR strains isolated from pigs 
in Germany were associated with integrons, which might have an important role in dissemi-
nation of resistance [46].
The majority of MDR isolates belonged to serovars S. Infantis and S. Kentucky. Among human iso-
lates of S. Kentucky, which is the seventh most common serovar, MDR was recorded at extremely 
high levels (76.3%) [5]. S. Kentucky ST198 clone that is displaying high-level resistance to ciproflox-
acin and frequently also to amoxicillin, streptomycin, spectinomycin, gentamicin, sulfamethoxa-
zole and tetracycline has been imported from North Africa and has been widely spread across 
Europe in humans and food production chain [32]. In addition, acquisition of extended-spectrum 
β-lactamase, plasmid-encoded cephalosporinase or carbapenemase in this clone was detected in 
Mediterranean area [47] and in Poland [33]. Combined resistance was also detected in S. Kentucky 
from humans and livestock in Belgium, Luxembourg, Malta, the Netherlands and Germany [5].
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S. Infantis was the most prevalent serovar in broilers and the fourth among human infec-
tions. Multi-drug resistance to FQ, sulfonamides and tetracyclines was observed frequently 
in the isolates from broilers (75.3%), broiler meat (72.6%), as well as in isolates from humans 
in two MS (Austria and Slovenia) that together with Hungary and Croatia accounted for a 
majority of the S. Infantis isolates from broilers. This indicates the presence of a specific MDR 
clone prevalent in this geographical region [5]. In addition, resistance to cephalosporins was 
recorded in the isolates from either humans, food or poultry in Great Britain [48], Switzerland 
[34], Italy [35], as well as in the USA [49], in some cases located on a plasmid and thus con-
ferring a risk of transfer. Such strains can be transmitted from broilers and broiler meat to 
humans and may lead to human infections [35].
4. Campylobacter
4.1. Prevalence of Campylobacter in the food chain
Whilst Campylobacter, with 246,307 confirmed infections in 2016 and 6.1% increase relative to 
2015, accounted for the majority of zoonoses in Europe, the death toll was low (0.03%). The 
highest notification rate per 100,000 population was observed in Eastern Europe (71.4), fol-
lowed by Western (65.7), Southern (56.3) and Northern Europe (55.0). Czech Republic (228.2) 
and Slovakia (140.5) were the countries with the highest prevalence [7].
Campylobacters were most frequently detected in turkeys (65.3%) and meat thereof (11%) as 
well as in broilers (27.3%) and meat thereof (36.7%) [7], making the poultry food production 
chain the main source of contamination. This is in concordance to data from several reports 
[50, 51]. The prevalence in retail poultry meat was, however, reported even up to almost 90% 
[50]. Campylobacter was also detected in cattle [52], pigs [53] and sheep [54]. Contaminated 
farm environment or equipment as well as the presence of Campylobacter in other animals and 
wildlife, were significantly associated with the prevalence of Campylobacter in poultry [55]. 
Furthermore, recent data suggest that human clinical C. jejuni isolates in Central Europe can 
be attributed to domesticated poultry, cattle livestock and environmental sources [56].
Outbreaks can be traced back to several sources (e.g., raw milk [57], water [58] and chicken liver 
pate [59]) and even associated with antimicrobial-resistant strains [57]. However, a limited number 
of highly contaminated products are most probably responsible for the majority of Campylobacter 
infections. Effective and harmonised surveillance systems, especially in the poultry food produc-
tion chain, that are oriented towards categorising risks should thus be established [50].
4.2. Antimicrobial resistance in Campylobacter
Campylobacter spp. in 2016 displayed extremely high resistance levels to FQ, which is par-
ticularly worrisome, as FQ are used as the first-line drugs against campylobacteriosis. 
Consequently, in some EU countries, FQ therapy of campylobacteriosis is no longer feasible. 
In average, the highest share of resistant isolates was detected in poultry and meat thereof, 
especially in the Member States of Southern and Eastern Europe (Figure 5) [5]. Data suggest 
that the use of FQ in livestock, specifically pigs, selects for FQ-resistant strains and accelerates 
the dissemination of such strains [60].
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In general, resistance to erythromycin, the second clinically important antimicrobial for 
treating campylobacteriosis, is generally uncommon; however, more resistant isolates were 
detected in pigs (21.6% in 2015), as seen in Figure 5 [22], which could reflect a wide use 
of macrolides for the treatment of common infections in pigs [61]. In contrast to C. jejuni 
from humans (2.1%), markedly higher erythromycin resistance level was observed in C. coli 
(11.0%), with the highest proportion in Estonia (63.2%) and Portugal (50%). Similar trends 
could be observed in isolates from livestock and food [5]. Similarly, high levels of resistance 
(62.4%) were recorded in C. coli from pigs in Spain [22] and even higher in Campylobacter 
isolates from poultry meat in Italy (72.1%) [62].
Resistance to macrolides in Campylobacter most commonly occurs via chromosomal mutations 
in 23S rRNA [63] that reduces the binding affinity of macrolides to the binding site. These 
mutations were, however, demonstrated to have a fitness cost and to slow growth rates [64]. 
Recently, transferrable erythromycin resistance, conferred by the rRNA methylase erm(B) 
gene and located on either plasmids or associated with chromosomal multidrug resistance 
genomic islands, was detected in humans and livestock [65].
Southern Europe in average recorded higher prevalence of resistance to tetracyclines, which 
may also be used for the treatment of campylobacteriosis in humans, and is, in addition to 
FQ resistance, a very common feature [5]. Marked variations in tetracycline resistance could 
be observed between C. coli and C. jejuni, countries and sources of isolation. Resistance rates 
varied from very low (<10%) in C. coli from pigs in Sweden [66], moderate in Campylobacter 
spp. from cattle in Poland (20.9%) [52], C. jejuni from broiler carcasses in Belgium (47%) [67] 
and C. jejuni from chicken meat in France (53.6%) [51] to extremely high in isolates of C. coli 
from pigs in France (93%) [66], as well as Campylobacter spp. from quails in Portugal (96.7%) 
[68]. In general, C. coli exhibited higher resistance levels [5].
Figure 5. Prevalence of resistance in Campylobacter spp. ERM: erythromycin, CIP: ciprofloxacin, TET: tetracyclines [5, 22].
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4.3. FQ resistance and combined/MDR resistance in Campylobacter
FQ resistance first emerged in Southeast Asia early in the 1990s with a rapid increase from 0 to 
84% over the period of 4 years [69] and has been widely spread to the other parts of the world, 
which might be due to an enhanced fitness of FQ-resistant isolates [70]. Significant portion 
of infections with FQ-resistant Campylobacter could be acquired through travel [71]. Extreme 
rates of FQ resistance in endemic areas [72] are therefore of concern.
In Europe, FQ resistance in Campylobacter spp. was extremely high, but it varied among the 
sources of isolation, species and countries. In average, isolates of C. coli exhibited markedly 
higher resistance rates than isolates of C. jejuni. As seen in Figure 6, turkey (96.8% in C. coli 
and 76.2% in C. jejuni) and meat thereof (100% in C. coli, 74.5% in C. jejuni) presented the main 
sources of resistance, closely followed by broilers and meat thereof [5].
A rapid increase in FQ resistance in Campylobacter is evident in the last 14 years [27]. In 
Slovenia, for instance, the resistance level to nalidixic acid rapidly increased in isolates from 
broiler meat from 49.1% in 2001–2003 [73] to 78.6% in 2006 [11]. In 2016, in average, 77.3% of 
Campylobacter spp. from broilers exhibited FQ resistance [5]. Recent data suggest the presence 
and clonal spread of FQ-resistant C. jejuni clonal complex ST-21 in central Europe (Slovenia, 
Germany, Austria) [74].
FQ resistance in C. jejuni (Figure 7) from broilers (in average 66.9%) varied from 8.4% in 
Finland to 97.9% in Latvia [5]. Furthermore, in 2014, Latvia reported on 100% resistant isolates 
Figure 6. Sources and prevalence of FQ-resistant isolates of C. jejuni (turkey, turkey meat, broilers, broiler meat and 
human, respectively) and C. coli (turkey meat, turkeys, broilers, broiler meat, humans and pigs, respectively) [5, 22].
Figure 7. Rates of FQ resistance in C. jejuni from broilers and humans, in C. coli from humans and combined resistance 
to FQ and erythromycin in C. coli from humans [5].
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of Campylobacter from chicken [75]. In humans, the highest rates of FQ resistance were reported 
for C. coli from Italy and Portugal (100%) and in for C. jejuni from Portugal and Estonia (>90%). 
Notably, 9 out of 19 EU MS recorded 80–100% resistance rates for C. coli (Figure 7) [5].
Overall, 9.2% of human C. coli exhibited combined resistance to ciprofloxacin, erythromy-
cin and tetracycline with resistance rates ranging from 0 to 57.9% (Estonia), which is shown 
in Figure 7 [5]. Erythromycin resistance is often associated with MDR phenotype [63]. In 
Finland, for example, 94.7% of Campylobacter isolates from humans were, in addition to eryth-
romycin, resistant to FQ, and 73.7% to tetracycline [76]. Combined resistance to the first-line 
drugs may be associated with adverse events such as delayed recovery, invasive illness and 
prolonged treatment with feasible alternative antimicrobials [77, 78].
FQ resistance in C. jejuni and C. coli can be mediated through specific point mutations in 
gyrA gene, encoding for DNA gyrase or through chromosomally encoded multidrug efflux 
pump. The two mechanisms work synergistically [79]. Efflux pumps in Campylobacter, pri-
marily CmeABC, are involved in resistance to broad spectrum of antimicrobials, including 
macrolides and quinolones [80], as well as cross-resistance to other compounds such as bile 
salts [81]. Therapeutic application of efflux pump inhibitors (e.g., epigallocatechin gallate) 
that were shown to restore macrolide efficacy could be a feasible treatment option in combina-
tion with the macrolide therapy [80, 82–84].
5. The role of whole genome sequencing in the surveillance of 
antimicrobial resistance of common zoonotic bacteria
The EU harmonised system on the monitoring and reporting of antimicrobial resistance in 
zoonotic and commensal bacteria (EC Decision 2013/652/EU; EFSA, EDSA) [12] is based on 
the phenotypic assessment of AMR of selected bacterial species (Salmonella, Campylobacter, 
E. coli) in selected food-producing animal species (poultry, pigs, cattle) and food products 
(chicken, pork, beef meat), using dilution methods (ISO standard 20776-1:2006, ISO standard 
20776-2:2007) and EUCAST epidemiological cut-off values (ECOFF-values) as interpretative 
criteria (EC Decision 2013/652/EU) [12]. In accordance with this legislation, 170 isolates are 
examined for antimicrobial susceptibility to a panel of 15 antimicrobial substances, for each 
combination of bacterial species and type of sample of animal population or food category 
each year by each member state. In 2016, ECDC also published EU protocol for harmonised 
monitoring of antimicrobial resistance in human Salmonella and Campylobacter isolates, aimed 
to increase the comparability of AMR data collected at the EU level from different Member 
States, and to improve the comparison of data among human isolates and isolates from ani-
mals and food products [13]. Beside dilution method as a preferred method, disk diffusion 
and gradient strip diffusion method are also allowed.
On the isolate level, genotyping of human isolates is also recommended, in terms of the 
assessment of resistance mechanisms and detection of the epidemic spread of resistance, par-
ticularly multi-drug resistant Salmonella, but it is not required in reporting [13].
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In recent years, the development of high-throughput technologies and platforms for massive 
DNA sequencing, and genomics tools has opened new possibilities also in the surveillance of 
AMR in common zoonotic bacteria. WGS, together with appropriate databases, general (NCBI, 
ENA) or specialised for AMR (ARG-ANNOT, ResFinder, CARD, RED-DB, Bacmet), bioinfor-
matic tools (BLAST) and platforms enable detection of antibiotic resistance genetic loci in the 
genomes of bacterial isolates or microbiomes and reveal the mechanisms leading to AMR. While 
WGS offers very rapid and efficient tool for detection of the antibiotic resistance genes (ARG) 
in genomes of individual bacterial isolates, the main issue remains how to predict from these 
data the actual antimicrobial susceptibility, and epidemiological or clinical cut-off values [85]. 
However, differentiation among isolates with acquired or intrinsic resistance on the basis of phe-
notypic MIC determinations only is also not totally accurate. Furthermore, it should be consid-
ered that also the strains that contain the genes associated with antimicrobial resistance but do 
not exhibit phenotypic resistance present certain risk for the horizontal spread when consumed.
The usefulness of WGS for antimicrobial resistance surveillance was confirmed in several 
studies. Examination of 640 nontyphoidal Salmonella isolates from retail meat and human 
clinical samples identified known resistance genes and phenotypic resistance to 14 antimi-
crobials, where the correlation between resistance genotypes and phenotypes was close to 
100% for most classes of antibiotics, and lower for aminoglycosides and beta-lactams [86]. 
In addition to known ARG, several unique resistance genes were found, more in the human 
isolates (n = 59) than in the retail meat isolates (n = 36). The authors concluded that the use of 
more appropriate MIC breakpoints and inclusion of new AGSs in the databases will further 
improve the correlations between phenotypic and genotypic observations. For Salmonella 
typhimurium isolates (n = 50) from Danish pigs, high concordance (99.74%) between pheno-
typic and predicted antimicrobial susceptibility was observed as well [87]. Phenotypic resis-
tance to quinolones and fluoroquinolones due to chromosomal mutations, however, could 
not be detected by ResFinder platform.
Genomic approach is increasingly used also in the developing of control methods and iden-
tification of antimicrobial resistance markers for evidence-based decisions in epidemiology 
and surveillance of foodborne diseases. OMICS datasets have been found as a powerful tool 
to complement current studies that are starting to be used also in some risk assessment areas. 
In a current comprehensive study “Syst-OMICS,” 4500 Salmonella genomes will be sequenced 
and analysis pipeline built in order to study Salmonella genome evolution, antibiotic resistance 
and virulence genes [88]. The data of the first 3377 genomes already sequenced are stored in 
the newly established Salmonella Foodborne Syst-OMICS database (SalFoS, https://salfos.ibis.
ulaval.ca/). Their analysis identified 1003 unique resistomes, composed of combinations of 
195 different genes. Surprisingly, the two most frequently observed resistomes accounted for 
23% of the Salmonella strains examined.
Comparative genomics of the WGS was successfully used also in the examination of 589 
Campylobacter isolates from retail chicken meat exhibiting phenotypic resistance to 9 antimicro-
bials [89]. For most antimicrobial agents (ciprofloxacin, nalidixic acid, gentamicin, azithromycin, 
erythromycin and clindamycin), the observed phenotypic resistance, determined on the basis 
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of the comparison of measured MICs with established ECOFF cut-off values, was in accordance 
with the presence of the known resistance genes or mutations. In the case of telithromycin, how-
ever, the observed point mutations in the 23S rRNA, which is a well-known mechanism of resis-
tance to these classes of antimicrobials, did not regularly cause phenotypic resistance. Another 
recent study on C. jejuni isolates from the poultry (n = 502) demonstrated successful use of 
genomics in the study of fluoroquinolone resistance [90]. The isolates were clustered according 
to the presence/absence of the gyrA mutations causing fluoroquinolone resistance. Beside the 
WGS of isolates from the mentioned study, previously published (ENA) Campylobacter genomes 
were included in the comparative analyses of the genomes. Although no significant associations 
were found between trade patterns, antimicrobial use in livestock and population of C. jejuni, 
this approach proved to be successful, especially when big datasets are available.
In conclusion, comparative genomics of WGS is increasingly used in the prediction of phe-
notypic antimicrobial resistance and surveillance of antimicrobial resistance of common zoo-
notic bacteria. However, as it is based on the detection of already known ARG, the success is 
highly dependent on the quality of databases, which need to be regularly updated with newly 
discovered resistance mechanisms and well-curated.
6. Conclusion
Antimicrobial resistant zoonotic bacteria pose a serious risk to human health. High rates of 
FQ resistance in both Salmonella and Campylobacter are of concern due to their wide use for the 
treatment of human infections. In some regions of the EU, the level of FQ resistance is so high 
that Campylobacter infections cannot be treated with FQ anymore. In addition, the emergence 
of multi-drug resistant Salmonella and Campylobacter further limits the therapy options and is 
possibly associated with adverse treatment effects. Greater efforts are needed to limit the wide 
spread of AMR in zoonotic bacteria—implementation of antimicrobial stewardship, especially 
in the developing countries, development of novel antimicrobials, improvement of practices in 
the food production chain, reduction of the amounts of antimicrobials sold for use in livestock, 
improvement of AMR surveillance programs, in terms of greater harmonisation, and applica-
tion of rapid sequence-based methods in the routine surveillance of antimicrobial resistance.
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